MODERN TREATMENT PRINCIPLES OF ANEMIA IN CHRONIC HEART FAILURE

Khuzhakulova F.I, Gadaev A.G, Nuritdinov N.A

Klinik fanlar yilnomasi · 2024-yil

Annotatsiya

The study comparatively examined the impact of standard therapy, including dapagliflozin, a type 2 sodium glucose cotransporter inhibitor, on hematological changes and intracardiac hemodynamics in patients with anemia and chronic heart failure. The increase in erythropoietin levels in the group of patients receiving dapagliflozin after treatment is associated with the drug's stimulating effect on erythropoietin production in the kidneys.

Maqola ma’lumotlari
MualliflarKhuzhakulova F.I, Gadaev A.G, Nuritdinov N.A
JurnalKlinik fanlar yilnomasi
Nashr sanasi2024-11-04
Jild1
Son3
TilO‘zbek

Kalit so‘zlar

chronic heart failure, dapagliflozin, anemia, ferritin, хроническая сердечная недостаточность, дапаглифлозин, анемия, ферритин, сурункали юрак етишмовчилиги, дапаглифлозин, камқонлик, ферритин

Ilmiy soha

Klinik fanlar yilnomasi jurnalidan boshqa maqolalar

Klinik fanlar yilnomasi — barcha maqolalar